Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Apollo Endosurgery stock | $3.62

Own Apollo Endosurgery stock in just a few minutes.

Fact checked

Apollo Endosurgery, Inc is a medical devices business based in the US. Apollo Endosurgery shares (APEN) are listed on the NASDAQ and all prices are listed in US Dollars. Apollo Endosurgery employs 217 staff and has a trailing 12-month revenue of around USD$41.2 million.

How to buy shares in Apollo Endosurgery

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Apollo Endosurgery. Find the stock by name or ticker symbol: APEN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Apollo Endosurgery reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$3.62, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Apollo Endosurgery, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Apollo Endosurgery. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Apollo Endosurgery share price

Use our graph to track the performance of APEN stocks over time.

Apollo Endosurgery shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$3.62
52-week rangeUSD$1.24 - USD$4.35
50-day moving average USD$3.2212
200-day moving average USD$1.9935
Wall St. target priceUSD$6.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.811

Buy Apollo Endosurgery shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Apollo Endosurgery stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Apollo Endosurgery price performance over time

Historical closes compared with the close of $3.62 from 2020-12-09

1 week (2021-01-15) -7.18%
1 month (2020-12-23) 2.26%
3 months (2020-10-22) 111.70%
6 months (2020-07-22) 106.86%
1 year (2020-01-22) 20.67%
2 years (2019-01-22) -7.18%
3 years (2018-01-22) 6.08
5 years (2016-01-22) 1,953.32%

Apollo Endosurgery financials

Revenue TTM USD$41.2 million
Gross profit TTM USD$25.7 million
Return on assets TTM -14.75%
Return on equity TTM -258.27%
Profit margin -63.88%
Book value $0.44
Market capitalisation USD$93.3 million

TTM: trailing 12 months

Shorting Apollo Endosurgery shares

There are currently 309,181 Apollo Endosurgery shares held short by investors – that's known as Apollo Endosurgery's "short interest". This figure is 2% down from 315,624 last month.

There are a few different ways that this level of interest in shorting Apollo Endosurgery shares can be evaluated.

Apollo Endosurgery's "short interest ratio" (SIR)

Apollo Endosurgery's "short interest ratio" (SIR) is the quantity of Apollo Endosurgery shares currently shorted divided by the average quantity of Apollo Endosurgery shares traded daily (recently around 210327.21088435). Apollo Endosurgery's SIR currently stands at 1.47. In other words for every 100,000 Apollo Endosurgery shares traded daily on the market, roughly 1470 shares are currently held short.

However Apollo Endosurgery's short interest can also be evaluated against the total number of Apollo Endosurgery shares, or, against the total number of tradable Apollo Endosurgery shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apollo Endosurgery's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Apollo Endosurgery shares in existence, roughly 10 shares are currently held short) or 0.0185% of the tradable shares (for every 100,000 tradable Apollo Endosurgery shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apollo Endosurgery.

Find out more about how you can short Apollo Endosurgery stock.

Apollo Endosurgery share dividends

We're not expecting Apollo Endosurgery to pay a dividend over the next 12 months.

Have Apollo Endosurgery's shares ever split?

Apollo Endosurgery's shares were split on a 10:55 basis on 30 December 2016. So if you had owned 55 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Apollo Endosurgery shares – just the quantity. However, indirectly, the new 450% higher share price could have impacted the market appetite for Apollo Endosurgery shares which in turn could have impacted Apollo Endosurgery's share price.

Apollo Endosurgery share price volatility

Over the last 12 months, Apollo Endosurgery's shares have ranged in value from as little as $1.24 up to $4.35. A popular way to gauge a stock's volatility is its "beta".

APEN.US volatility(beta: 2.46)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Endosurgery's is 2.4629. This would suggest that Apollo Endosurgery's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Apollo Endosurgery overview

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site